when was glp-1 discovered JCI Frontiers | GLP-1R in diabetes
Description
Consult with a healthcare provider for personalized injection site guidance
Efficacy and weight loss outcomes Clinical trials demonstrate distinct results: Zepbound : Participants lost 20.2% of body weight on average (50.3 lbs) over 72 weeks in SURMOUNT-5 trials
Gastrointestinal side effects such as nausea are typically most pronounced during the first few weeks and following dose increases, generally improving as your body adapts to the medication over 12 weeks
Dalle Grave, R., Sartirana, M., El Ghoch, M., & Calugi, S
